Together with Sanofi, we're developing VCGs to reduce the need for animals in research
Unlock the Potential of Virtual Control Groups
Charles River and Sanofi will collaborate to pilot VCGs in nonclinical toxicology programs with the goal of reducing animal usage by replacing selected control group animals with selected matched virtual control animals developed using retrospective datasets.
In a typical animal study, approximately 25% of the animals are used as controls. VCGs have the capability to reduce the number of animals needed for these studies by reusing the measurement data gathered from these control groups. The joint vision of this initiative is to combine the science of toxicology with the power of machine learning to drive greater use of VCGs for nonclinical research across the industry. Read more >
Charles River’s QC microbiology testing portfolio brings you modern products and services that deliver accurate, relevant, and reliable data to allow you to make confident decisions on your product quality and contamination control. Our unique combination of Endosafe® endotoxin testing, Celsis® rapid microbial detection, and Accugenix® microbial identification and strain typing keeps your manufacturing operations running efficiently and smoothly, lowers your cost to manufacture, and protects your reputation.
